Skip to content

effect of Varanadi kwatha Bhavitha Shilajatu internal administration in Colorectal Carcinoma

Effect of Varanadi kwatha Bhavitha Shilajatu in Colorectal Carcinoma - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085407
Enrollment
21
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C20- Malignant neoplasm of rectum

Interventions

None listed

Sponsors

Government Ayurveda College Trippunithura, Ernakulam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of colorectal carcinoma after attaining a written consent

Exclusion criteria

Exclusion criteria: Hb level less than 8g/dl Carcinoembryonic antigen level (CEA) above 600ng/ml of blood

Design outcomes

Primary

MeasureTime frame
Assessment of CEA value Timepoint: Assessment of CEA value on 0th and 31st day

Secondary

MeasureTime frame
Assessment of TWBC value Assessment of ESR value Assessment of Hb % Assessment of Fecal occult blood Assessment of EORTC QLQ CR 29 - quality of life questionnaire for colorectal cancer cancerTimepoint: Assessment of TWBC value on 0th,15th,31st day Assessment of ESR value on 0th,15th,31st day Assessment of Hb % on 0th,15th,31st day Assessment of Fecal occult blood on 0th,15th,31st day Assessment of EORTC QLQ CR 29 - quality of life questionnaire for colorectal cancer cancer on 0th,15th,31st day

Countries

India

Contacts

Public ContactDr M M Abdul Shukkoor

Government Ayurveda College Trippunithura, Ernakulam

drsukoor@gmail.com9447661001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026